Please assess the completion status of the following clinical trial:

Trial Title: A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com~Inclusion Criteria:~* Male or female between 21 and 75 years old~* Body Mass Index (BMI) of 25 or more~Exclusion Criteria:~* Chronic Liver disease other than NASH~* Uncontrolled diabetes~* Any major surgery within 6 weeks of screening~* Unable to self-administer under the skin injections~* Any bone trauma, fracture or bone surgery within 8 weeks of screening

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Group A: BMS-986036 (Type: EXPERIMENTAL): Administered as specified on specified days
- Treatment Group B: BMS-986036 (Type: EXPERIMENTAL): Administered as specified on specified days
- Treatment Group C: Placebo (Type: PLACEBO_COMPARATOR): Administered as specified on specified days

Based on this trial design, predict the completion outcome and termination type (if applicable).